| Anna Tomes, OTR/L | |
|
1882 Clairmont Rd, Decatur, GA 30033-3420 | |
| (404) 664-1533 | |
| Not Available |
| Full Name | Anna Tomes |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 1882 Clairmont Rd, Decatur, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043856479 | NPI | - | NPPES |
| Provider Name | Aegis Group Practice Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1881142750 PECOS PAC ID: 5193036432 Enrollment ID: O20150916001644 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee (IDMC). This decision was based upon completion of the second and final planned interim futility analysis.
In response to cases of swine influenza A(H1N1), reported in Mexico and the United States of America, the Director-General convened a meeting of the Emergency Committee to assess the situation and advise her on appropriate responses.
Coinciding with the World Health Organization (WHO) European Ministerial Conference on the Prevention and Control of Non-Communicable Diseases in Turkmenistan, MEPs, patient and physician representatives are today meeting at the European Parliament to highlight that urgent national action is required to prevent stroke.
Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anna Tomes, OTR/L 1882 Clairmont Rd, Decatur, GA 30033-3420 Ph: (404) 664-1533 | Anna Tomes, OTR/L 1882 Clairmont Rd, Decatur, GA 30033-3420 Ph: (404) 664-1533 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee (IDMC). This decision was based upon completion of the second and final planned interim futility analysis.
In response to cases of swine influenza A(H1N1), reported in Mexico and the United States of America, the Director-General convened a meeting of the Emergency Committee to assess the situation and advise her on appropriate responses.
Coinciding with the World Health Organization (WHO) European Ministerial Conference on the Prevention and Control of Non-Communicable Diseases in Turkmenistan, MEPs, patient and physician representatives are today meeting at the European Parliament to highlight that urgent national action is required to prevent stroke.
Researchers have discovered how a gene involved in regulating hormone receptors may contribute to drug resistance in some prostate cancer patients.
› Verified 2 days ago